Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC722421895;21896;21897 chr2:178723430;178723429;178723428chr2:179588157;179588156;179588155
N2AB690720944;20945;20946 chr2:178723430;178723429;178723428chr2:179588157;179588156;179588155
N2A598018163;18164;18165 chr2:178723430;178723429;178723428chr2:179588157;179588156;179588155
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTC
  • RefSeq wild type template codon: GAG
  • Domain: Ig-56
  • Domain position: 88
  • Structural Position: 174
  • Q(SASA): 0.0633
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F rs747568681 -1.355 1.0 D 0.835 0.578 0.639540451167 gnomAD-2.1.1 4.05E-06 None None None None N None 0 0 None 0 0 None 3.31E-05 None 0 0 0
L/F rs747568681 -1.355 1.0 D 0.835 0.578 0.639540451167 gnomAD-4.0.0 1.59592E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.43947E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.8749 likely_pathogenic 0.8953 pathogenic -2.606 Highly Destabilizing 0.999 D 0.747 deleterious None None None None N
L/C 0.8511 likely_pathogenic 0.8701 pathogenic -1.865 Destabilizing 1.0 D 0.863 deleterious None None None None N
L/D 0.9979 likely_pathogenic 0.9986 pathogenic -2.916 Highly Destabilizing 1.0 D 0.892 deleterious None None None None N
L/E 0.9886 likely_pathogenic 0.9914 pathogenic -2.588 Highly Destabilizing 1.0 D 0.883 deleterious None None None None N
L/F 0.4925 ambiguous 0.6049 pathogenic -1.561 Destabilizing 1.0 D 0.835 deleterious D 0.5244156 None None N
L/G 0.9724 likely_pathogenic 0.9783 pathogenic -3.244 Highly Destabilizing 1.0 D 0.88 deleterious None None None None N
L/H 0.9598 likely_pathogenic 0.9723 pathogenic -2.891 Highly Destabilizing 1.0 D 0.861 deleterious D 0.55761237 None None N
L/I 0.1645 likely_benign 0.1741 benign -0.703 Destabilizing 0.999 D 0.55 neutral N 0.50219306 None None N
L/K 0.9842 likely_pathogenic 0.988 pathogenic -1.992 Destabilizing 1.0 D 0.898 deleterious None None None None N
L/M 0.3164 likely_benign 0.3663 ambiguous -0.791 Destabilizing 1.0 D 0.804 deleterious None None None None N
L/N 0.9843 likely_pathogenic 0.9877 pathogenic -2.652 Highly Destabilizing 1.0 D 0.893 deleterious None None None None N
L/P 0.9877 likely_pathogenic 0.9905 pathogenic -1.325 Destabilizing 1.0 D 0.893 deleterious D 0.55761237 None None N
L/Q 0.9502 likely_pathogenic 0.9611 pathogenic -2.278 Highly Destabilizing 1.0 D 0.898 deleterious None None None None N
L/R 0.9561 likely_pathogenic 0.9646 pathogenic -2.077 Highly Destabilizing 1.0 D 0.893 deleterious D 0.55761237 None None N
L/S 0.97 likely_pathogenic 0.979 pathogenic -3.337 Highly Destabilizing 1.0 D 0.891 deleterious None None None None N
L/T 0.9181 likely_pathogenic 0.9339 pathogenic -2.827 Highly Destabilizing 1.0 D 0.865 deleterious None None None None N
L/V 0.1817 likely_benign 0.186 benign -1.325 Destabilizing 0.999 D 0.545 neutral N 0.485108628 None None N
L/W 0.9137 likely_pathogenic 0.9458 pathogenic -1.934 Destabilizing 1.0 D 0.849 deleterious None None None None N
L/Y 0.8962 likely_pathogenic 0.9276 pathogenic -1.668 Destabilizing 1.0 D 0.875 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.